Detalhe da pesquisa
1.
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
Cardiovasc Diabetol
; 23(1): 22, 2024 01 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38195491
2.
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
Cardiovasc Diabetol
; 20(1): 229, 2021 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34823531
3.
Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database Analysis.
Alcohol Alcohol
; 56(5): 545-555, 2021 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33969378
4.
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study.
Europace
; 22(2): 205-215, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31638652
5.
Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study.
Eur Arch Psychiatry Clin Neurosci
; 270(1): 3-10, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30539229
6.
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.
Stroke
; 50(9): 2469-2476, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31390972
7.
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation.
Br J Clin Pharmacol
; 85(2): 432-441, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30423205
8.
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.
Br J Clin Pharmacol
; 83(9): 2056-2065, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28345154
9.
A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.
Br J Clin Pharmacol
; 81(3): 569-78, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26493768
10.
Corrigendum to: Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database Analysis.
Alcohol Alcohol
; 56(5): 634, 2021 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34100061
11.
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study.
Vaccines (Basel)
; 12(3)2024 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38543875
12.
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.
Drug Saf
; 46(4): 391-404, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37024736
13.
Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
Pharmacoepidemiol Drug Saf
; 21(11): 1183-9, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22972760
14.
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.
Br J Clin Pharmacol
; 71(1): 121-7, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21143508
15.
Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims database.
MethodsX
; 7: 100796, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32322541
16.
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Am J Cardiovasc Drugs
; 20(1): 81-103, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31254174
17.
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation.
Clin Pharmacol Ther
; 105(6): 1439-1455, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30499605
18.
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France.
Therapie
; 74(4): 469-476, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30857740
19.
Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI.
Therapie
; 74(4): 459-468, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30878144
20.
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.
Atherosclerosis
; 281: 98-106, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30658197